[Table_RightTitle] 策略研究|策略跟踪报告 | --- | --- | --- | |---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

[Table_Title] 万联晨会 [Table_MeetReportDate] 2024 年 09 月 12 日 星期四 证 券 研 究 报 告 晨会纪要 市场研究 3239 | --- | --- | --- | --- | |-------------------------------------------------------------------------------|---------------------------------------|------------------------|--------| | [Table_Summary] \n概览 | [Table_InnerMarketIndex] 国内市场表现 | \n指数名称 收盘 涨跌幅 | % | | | 上证指数 | 2,721.80 | -0.82% | | 核心观点 | 深证成指 | 8,105.38 | 0.39% | | 【市场回顾】 | 沪深 300 | 3,186.13 | -0.30% | | 周三，A 股三大股指走势分化，上证指数跌 0.82%，报 2721.8 点，深 | 科创 50 | 664 ...

[Table_RightTitle] 证 券 研 究 报 告 行业跟踪报告 行业研究 证券研究报告|美容护理 | --- | --- | --- | |---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

[Table_RightTitle] 证券研究报告|家用电器 证 券 研 究 报 告 行业跟踪报告 行业研究 [Table_Title] 家电行业 2024H1 业绩综述 [Table_IndustryRank] 强于大市(维持) [Table_ReportType] ——家用电器行业跟踪报告[Table_ReportDate] 2024 年 09 月 11 日 [行业核心观点： Table_Summary] 2024 年 Q2 家电行业整体业绩增速有所回落，其中白电及小家电表现较 好，行业内销 6 月起有所走弱，外销景气度维持较高，国内以旧换新政 策持续推进，预计后续将对内销有一定支撑，从细分领域角度看，白电 在内外销均表现更佳，我们维持行业"强于大市"评级，建议持续关注 经营稳健具有较高分红预期的龙头标的、出口链相关机会以及具有第二 增长曲线的相关个股。 投资要点： ⚫ 24H1 业绩增速有所回落，白电及小家电表现较好：收入端，2024 年上半年家用电器行业营业收入规模为 7660.0 亿元，同比增长 6.4%。分行业来看，2024H1 小家电行业营收同比增速表现突出， 带动家电行业增长：小家电（10.6 ...

[Table_Title] 万联晨会 [Table_MeetReportDate] 2024 年 09 月 11 日 星期三 [Table_Summary] 概览 核心观点 【市场回顾】 周二，A 股主要股指筑底回升，上证综指涨 0.28%，报 2744.19 点， 深证成指涨0.13%，创业板指涨0.06%。A股两市全天成交额约5275.05 亿元人民币，超 3100 只个股上涨。南向资金净买入 92.89 亿港元。 申万行业方面，计算机、通信行业领涨，房地产、建筑材料行业领跌； 概念板块方面，F5G 概念、可燃冰板块涨幅居前，芬太尼、高压氧舱 板块跌幅居前。港股方面，香港恒生指数涨 0.22%，恒生科技指数涨 0.41%。海外方面，美国三大股指涨跌不一，道指跌 0.23%，标普 500 指数涨 0.45%，纳指涨 0.84%。欧洲股市全线收跌，亚太股市收盘涨 跌互现。 【重要新闻】 【十四届全国人大常委会第十一次会议召开】十四届全国人大常委会 第十一次会议 10 日上午在北京人民大会堂举行第一次全体会议。赵 乐际委员长主持，常委会组成人员 159 人出席会议。会议听取或审议 了多个领域的报告或议案。其中， ...

[Table_RightTitle] 宏观研究|宏观跟踪报告 证 券 研 究 报 告 宏观跟踪报告 宏观研究 | --- | --- | --- | --- | |----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

[Table_Title] 万联晨会 [Table_MeetReportDate] 2024 年 09 月 10 日 星期二 [Table_Summary] 概览 核心观点 【市场回顾】 周一，A 股三大股指涨跌不一，上证指数跌 1.06%，报 2736.49 点； 深证成指跌 0.83%，创业板指涨 0.06%。两市 A 股成交额 5184 亿元人 民币，超 2900 股下跌。南向资金净买入 58.28 亿港元。申万行业方 面，综合、社会服务行业涨幅居前，煤炭行业跌幅居前；概念板块方 面，高压氧舱、细胞免疫治疗、民营医院概念行业领涨。港股方面， 香港恒生指数跌 1.42%，恒生科技指数跌 1.46%。海外方面，美国三 大股指全线收涨，道指涨 1.20%，标普 500 指数涨 1.16%，纳指涨 1.16%。欧洲股市全线上涨，亚太股市涨跌不一。 【重要新闻】 【国家统计局发布 2024 年 8 月份全国 CPI（居民消费价格指数）数 据】2024 年 8 月份，全国居民消费价格同比上涨 0.6%。其中，城市 上涨 0.6%，农村上涨 0.8%；食品价格上涨 2.8%，非食品价格上涨 0.2%；消费品价格上涨 ...

Investment Rating - The industry investment rating is "Outperform the Market" with an expectation of over 10% relative increase in the industry index compared to the market in the next six months [31]. Core Insights - The blood products industry is experiencing steady growth, with listed companies showing robust financial performance and plasma collection volume. The industry is undergoing accelerated consolidation through mergers and acquisitions [1][3]. - The demand for blood products is expected to increase due to the growing elderly population, particularly in first-tier cities, leading to market expansion. Additionally, there is significant room for improvement in per capita consumption of blood products in China compared to international levels [26]. - The supply side has seen a steady increase in the number of plasma collection stations and plasma collection volume over the past few years, with several provinces launching construction plans for plasma stations [26]. Summary by Sections Blood Product Stock Review - Over the past year (September 7, 2023, to September 6, 2024), the blood products sector (Shenwan) increased by 10.65%, outperforming the pharmaceutical and biological sector by 30.05 percentage points and the CSI 300 index by 24.67 percentage points [7][9]. - Among the six listed blood product companies, the highest absolute increase was seen in Palin Biological (+50.17%), followed by Tiantan Biological (+32.35%) and Boya Biological (+27.96%) [9]. Blood Product 2024H1 Performance Overview - In 2024H1, companies such as Palin Biological, Shanghai Laisai, Weiguang Biological, and Tiantan Biological reported year-on-year growth in both operating revenue and net profit attributable to shareholders [13][14]. - The plasma collection volume for the first half of 2024 showed double-digit year-on-year growth for all companies that disclosed their data, with Palin Biological collecting 700 tons (+27.27%) and Tiantan Biological 1294 tons (+15.02%) [15][17]. Mergers and Acquisitions in Blood Product Companies - The blood products industry has a high entry barrier due to strict regulatory policies, leading to accelerated consolidation through mergers and acquisitions. Currently, there are about 30 operational blood product manufacturers in China, with the number expected to decrease as consolidation continues [19][26]. - Recent acquisition cases include Boya Biological acquiring Hong Kong Red Cross and Tiantan Biological acquiring Zhongyuan Ruide [19][20]. Analysis of Unlisted Blood Product Manufacturers - The report identifies several unlisted blood product manufacturers based on batch issuance data, with Shandong Taibang having the most records across various products [23][24]. Investment Recommendations - The report suggests that the blood products sector has high entry barriers and is likely to see increased concentration through mergers. It recommends focusing on companies like Tiantan Biological, Boya Biological, and Palin Biological due to their competitive advantages in plasma resource acquisition and R&D capabilities [26].

[Table_RightTitle] 策略研究|策略跟踪报告 | --- | --- | --- | --- | |---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

[Table_Title] 万联晨会 [Table_MeetReportDate] 2024 年 09 月 09 日 星期一 [Table_Summary] 概览 核心观点 【市场回顾】 上周五，A 股三大股指全部收跌，上证指数跌 0.81%，报 2765.81 点， 深证成指跌 1.44%，创业板指跌 1.7%。两市 A 股成交额 5424 亿元人 民币，约 4500 股下跌。申万行业方面，仅非银金融和银行行业上涨， 美容护理行业领跌；概念板块方面，网约车、海南自贸区概念涨幅居 前。港股因台风原因休市一天。海外方面，美国三大股指全线收跌， 道指跌 1.01%，标普 500 指数跌 1.73%，纳指跌 2.55%。欧洲股市全 线下跌，亚太股市多数下跌。 【重要新闻】 【证监会发布《证监会系统离职人员入股拟上市企业监管规定（试 行）》】为进一步加强证监会系统离职人员（以下简称离职人员）入股 拟上市企业的管理，维护资本市场的公开、公平、公正，证监会发布 《证监会系统离职人员入股拟上市企业监管规定（试行）》（以下简称 《离职人员监管规定》）。《离职人员监管规定》吸纳了《2 号指引》的 主要内容，并新增三方面规定：一 ...